In conclusion, in a well-characterized cohort of non-obese, non-diabetic, biopsy-proven NAFLD individuals, increased irisin levels are found in individuals with significant fibrosis and are correlated with increased liver fibrogenesis, potentially identifying a more aggressive phenotype of liver disease. This evidence concerns the gene FNDC5 and metabolic dysfunction-associated steatotic liver disease.